TWO-YEAR SURVIVAL WITH AXICABTAGENE CILOLEUCEL IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: AN UPDATED ANALYSIS

EHA Library, Tiffany Adolf, 267536

PROGRAMMED CELL DEATH-1 AND PROGRAMMED CELL DEATH LIGANDS EXPRESSION IN NODAL PERIPHERAL T-CELL LYMPHOMA

EHA Library, Kitsada Wudhikarn, 267537

DURABILITY OF COMPLETE RESPONSE AFTER BLINATUMOMAB THERAPY FOR REFRACTORY/RELAPSED AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Carine Thual, 267538

HOW TO PREDICT EARLY PROGRESSION IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Aya Nakaya, 267539

INCREASED RISK OF HIP FRACTURES IN YOUNG WOMEN WITH LYMPHOMA, RESULTS FROM A SWEDISH POPULATION BASED STUDY

EHA Library, Peter Johansson, 267540

OUTCOME OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FIRST COMPLETE REMISSION IN PATIENTS WITH LOW-RISK PERIPHERAL T-CELL LYMPHOMAS (PTCLS)

EHA Library, Haiwen Huang, 267541

REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) PATIENTS INITIATED ON ANTI-CANCER THERAPIES IN THE UNITED STATES (US)

EHA Library, Guillaume Germain, 267542

CLINICAL FEATURES AND PROGNOSTIC FACTORS OF PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA (PT-DLBCL): EXPERIENCE OF 35 PATIENTS FROM FUSCC

EHA Library, Fang-Fang Lv, 267543

REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS INITIATED ON ANTI-CANCER THERAPIES IN THE UNITED STATES (US)

EHA Library, Guillaume Germain, 267544

SEZARY SYNDROME TREATMENT AND OTHER T-CELL CUTANEOUS LYMPHOMAS WITH EXTRACORPOREAL PHOTOPHERESIS: RESULTS FROM 157 PROCEDURES IN ELEVEN PATIENTS IN COLOMBIA

EHA Library, Leonardo Enciso-Olivera, 267545

PRALATREXATE EXPERIENCE IN NON HODGKIN LYMPHOMA

EHA Library, Leonardo Enciso-Olivera, 267546

EPISTAXIS IN PEDIATRIC TERTIARY OUT-PATIENT CLINIC: COULD IT BE AN ALARMING SIGN?

EHA Library, Fatma Soliman Ebeid, 267547

ACQUIRED HEMOPHILIA AND MONOCLONAL GAMMOPATHY OF HEMOSTASIC SIGNIFICANCE

EHA Library, FERNANDO ESCALANTE BARRIGON, 267548

ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR IN A MILD HAEMOPHILIA A PATIENT: A CASE REPORT

EHA Library, Manuel Rodriguez Lopez, 267549

CONGENITAL COMBINED DEFECTS OF COAGULATION FACTORS FVII AND FX : ABOUT A TUNISIAN FAMILY.

EHA Library, Fatma Megdich, 267550

WHEN DO WE HAVE TO SUSPECT AND DIAGNOSE VON WILLEBRAND DISEASE?

EHA Library, Shin Young Hyun, 267551

HEPATITIS ASSOCIATED APLASTIC ANEMIA: ETIOLOGY, CLINICAL CHARACTERISTICS AND OUTCOME

EHA Library, Şebnem Yılmaz, 267552

PERSISTENT COMPLEMENT ACTIVATION IS PROVOKED BY IGG-AGGREGATES IN A SUB-POPULATION OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Regina Michelis, 267553

IS THERE A ROLE OF VITAMIN D IN THE PATHOPHYSIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA?

EHA Library, Stavroula Ntoufa, 267554

MULTIPARAMETRIC FLOW-CYTOMETRY ANALYSIS OF SURFACE MARKERS EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: PATHOGENIC AND PROGNOSTIC IMPLICATIONS.

EHA Library, Umberto Falcone, 267555

HIGH CXCR3 AND CXCR5 DISTINGUISH IGHVMUT FROM IGHVUNMUT CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FROM CD5HIGH AND CD5LOW CLONES

EHA Library, Gabriela Gabcova, 267556

GENOMIC CHARACTERIZATION OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA: ROLE OF ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH)

EHA Library, Raquel Alves, 267557

VENETOCLAX ALONE OR IN COMBINATION WITH RITUXIMAB FOR JAPANESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ryan Bourgo, 267558

CLINICO-BIOLOGICAL FEATURES AND OUTCOMES OF ACCELERATED PHASE CHRONIC LYMPHOCYTIC LEUKEMIA (AP-CLL) IN THE ERA OF TARGETED AGENTS.

EHA Library, Jacqueline Barrientos, 267559

REAL WORLD TREATMENT PERSISTENCE OF NEW ZEALAND IBRUTINIB CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN A NAMED PATIENT PROGRAM

EHA Library, Andrea PUIG, 267560

NON-INTERVENTIONAL RETROSPECTIVE MULTICENTER STUDY EVALUATING REAL WORD IDELALISIB USE IN CLL AND INHL PATIENTS ENROLLED IN THE FRENCH EARLY ACCESS PROGRAM (EAP)

EHA Library, Loic Ysebaert, 267561

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WITH INCREASED SERUM VON WILLEBRAND LEVELS AT DIAGNOSIS HAVE A SHORTER TIME TO TREATMENT

EHA Library, Annita-Ioanna Gkioka, 267562

MANAGEMENT OF AUTOIMMUNE CYTOPENIA COMPLICATING CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maksym Semerak, 267563

PURGING WITH CHLORAMBUCIL TO PREVENT INFUSION-RELATED REACTIONS BEFORE OBINUTUZUMAB ADMINISTRATION: A MONOCENTRIC PILOT EXPERIENCE.

EHA Library, Idanna Innocenti, 267564

PONATINIB LONG-TERM FOLLOW-UP OF EFFICACY AND SAFETY IN CP-CML PATIENTS IN REAL WORLD SETTINGS IN FRANCE: THE POST-PACE STUDY

EHA Library, Gabriel Etienne, 267565

QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE AFTER STOPPING TREATMENT BY TYROSINE KINASE INHIBITORS AT LONG-TERM FOLLOW-UP

EHA Library, Tatiana Nikitina, 267566

LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR DURING TREATMENT OF CML PATIENTS WITH IMATINIB – A RETROSPECTIVE ANALYSIS

EHA Library, Kostyantyn KOTLYARCHUK, 267567

DOES STEPWISE DOSE ESCALATION METHOD OF NILOTINIB FOR CML IMPROVE MR4.5 AND TREATMENT FREE REMISSION　?

EHA Library, Kohmei Kubo, 267568

REAL LIFE DATA OF NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RESISTANT OR INTOLERANT TO IMATINIB

EHA Library, Tayfun Elibol, 267569

COEXISTENCE OF BCR/ABL1 AND JAK2 MUTATION IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Ferdinando Frigeri, 267570

CHRONIC MYELOID LEUKEMIA DEVELOPING AFTER SYSTEMIC MASTOCYTOSIS: FAST AND COMPLETE MOLECULAR RESPONSE INDUCED BY IMATINIB.

EHA Library, Juan Luis Steegmann, 267571

ROLE OF HOMOCYSTEINE AND METHILMALONIC ACID IN NEUROLOGICAL PATHOLOGY

EHA Library, Mario Andrés Legarda Campo, 267572

HYPERVITAMINOSIS B12 MEDIATED BY INMUNE COMPLEXES IN PATIENTS WITH VITAMIN B12 DEFIENCY, VALUE OF HOMOCYSTEIN AND METHYLMALONIC ACID ASSESSMENT

EHA Library, Mario Andrés Legarda Campo, 267573

LATE DIAGNOSIS IN SYRIAN IMMIGRANT PATIENT; THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME

EHA Library, Vahap Okan, 267574

SHORT-TERM APPLICATION OF CAFFEIC ACID SPECIFICALLY PROMOTES EXPANSION OF HEMATOPOIETIC STEM CELLS

EHA Library, Yang Liu, 267575

THE CHANGE OF BONE MARROW MICROENVIRONMENT OF SECONDARY POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AND ITS EFFECT ON PROGNOSIS

EHA Library, Yao Liu, 267576

EFFICACY OF ANTI-NEUTROPHIL ANTIBODIES TESTING IN PREDICTING CLINICAL OUTCOMES AND SPONTANEOUS RESOLUTION OF NEUTROPENIA IN CHILDREN: A SINGLE CENTER EXPERIENCE

EHA Library, Kyung Mi Park, 267577

PROGNOSTICATION OF HODGKIN’S LYMPHOMA BY IPET AND IPS: UPDATE DATA OF 8 HEMATOLOGICAL UKRAINIAN CENTERS.

EHA Library, Tetiana Skrypets, 267578

AN OPEN-LABEL STUDY OF BENDAMUSTINE HYDROCHLORIDE IN CHINESE PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA (NHL) REFRACTORY TO RITUXIMAB TREATMENT

EHA Library, YuanKai Shi, 267579

FOLLICULAR LYMPHOMA: A CHOICE OF FIRST-LINE THERAPY

EHA Library, Ekaterina Nesterova, 267580

RESULTS OF TREATMENT PATIENTS OF MANTLE CELL LYMPHOMA DEPENDING ON THE MUTATIONAL STATUS OF THE TP53 GENE

EHA Library, Evgeniy Zvonkov, 267581

ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN WITH ACUTE LEUKEMIA

EHA Library, Şebnem Yılmaz, 267582

INVASIVE ASPERGILLOSIS IN ELDERLY ONCOHEMATOLOGICAL PATIENTS

EHA Library, Olga Shadrivova, 267583

IMMUNOGLOBULIN REPLACEMENT THERAPY IN ADULT HEMATOLOGICAL PATIENTS: EFFECT ON THE INCIDENCE OF INFECTIOUS COMPLICATIONS

EHA Library, Igor Stoma, 267584

INVASIVE ASPERGILLOSIS IN PEDIATRIC PATIENTS WITH MALIGNANCIES

EHA Library, Nikolai Klimko, 267585

EVOLUATION OF CLINICAL MANIFESTATION IN FEBRILE NEUTROPENIC PATIENTS

EHA Library, Huseyin Saffet Bekoz, 267586

EMERGENT INFECTIONS ASSOCIATED TO THE TREATMENT WITH NEW MOLECULES IN CHRONIC LYMPHOCYTIC LEUKEMIA - SINGLE CENTER EXPERIENCE

EHA Library, Iulia Ursuleac, 267587

UPPER AND LOWER GASTROINTESTINAL ENDOSCOPY FINDINGS IN PATIENTS WITH ISOLATED FERRITIN DEFICIENCY

EHA Library, Aysenur BAHADİR, 267588

ACUTE IRON OVERLOAD WITH IRON CARBOXYMALTOSE:CASE REPORT

EHA Library, murat çınarsoy, 267589

PDL1 IS HIGHLY EXPRESSED BY AGGRESSIVE NK-CELL LEUKEMIA/LYMPHOMA AND ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Qing Chen, 267590

HOVON PATHOLOGY FACILITY AND BIOBANK: AN EFFICIENT PLATFORM FOR PATHOLOGY REVIEW AND TRANSLATIONAL STUDIES FOR CLINICAL TRIALS IN LYMPHOMA PATIENTS.

EHA Library, Nathalie Hijmering, 267591

HIGH PREVALENCE OF NON-GERMINAL CENTER B-CELL PHENOTYPE WITH MYC OVEREXPRESSION IN JAPANESE PATIENTS WITH INTRAVASCULAR LARGE B-CELL LYMPHOMA

EHA Library, Katsuhiro Miura, 267592

DIAGNOSTIC VALUE OF THE NEW SYSMEX XN 2000 AUTOANALIZER IN THE STUDY OF LYMPHOCYTOSIS.

EHA Library, Fernanda Díaz Suarez, 267593

RETROSPECTIVE ANALYSIS OF ADOLESCENT AND YOUNG ADULT (AYA) WITH LYMPHOMA IN JAPAN

EHA Library, Aya Nakaya, 267594

INFLAMMATION & ADIPOSITY CIRCULATORY MARKERS IN B-NON HODGKIN LYMPHOMA (B-NHL): AN EGYPTIAN SINGLE CENTER STUDY

EHA Library, Doaa El Demerdash , 267595

AUTOMATED EARLY DETECTION OF MYELODYSPLASIA WITH BECKMAN-COULTER DXH 800 HEMATOLOGY ANALYZER BY USING TEN RESEARCH PARAMETERS

EHA Library, Olivier Herault, 267596

IMPLEMENTATION AND VALIDATION OF A COLLABORATIVE PLATFORM FOR LONGITUDINAL BIOBANKING OF VIABLE CELLS AND PLASMA IN MYELOID NEOPLASMS

EHA Library, Nicolas Bonadies, 267597

OUTCOME AFTER AZACITITINE TREATMENT IN PATIENTS WITH HIGH-RISK MYEOLODYSPLASTIC SYNDROME, CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE 2 AND ACUTE MYELOID LEUKEMIA – A SINGLE CENTER EXPERIENCE

EHA Library, Victoria Varbanova, 267598

HIGH PLASMA CELL PROLIFERATIVE INDEX IS ASSOCIATED WITH A DOMINANT EXPANSION OF A SINGLE IMMUNOPHENOTYPIC SUBCLONE AND PREDICTS RESPONSE TO LENALIDOMIDE/DEXAMETHASONE IN RELAPSED MULTIPLE MIELOMA.

EHA Library, Fabian Tarin Rodrigo, 267599

IDENTIFICATION OF NOVEL REGULATORS OF PLASMA CELLS MIGRATION IN MULTIPLE MYELOMA PATIENTS

EHA Library, Alexander Vdovin, 267600

LOCKED NUCLEIC ACID MODIFIED OLIGONUCLEOTIDE MIMICKING MIR-15A SUPPRESSES TUMOR CELLS PROLIFERATION IN VITRO

EHA Library, Jie Xu, 267601

IMPACT OF CLONAL HETEROGENEITY IN COMPLEX KARYOTYPES OF MULTIPLE MYELOMA PATIENTS WITH FIRST LINE BORTEZOMIB-BASED THERAPY: A SINGLE-INSTITUTION EXPERIENCE IN BULGARIA

EHA Library, Kameliya Milcheva, 267602

EVOLUTION OF MULTIPLE MYELOMA MANAGEMENT IN NORWAY: EXPERT OPINION 2013 – 2018.

EHA Library, Fredrik Hellem Schjesvold, 267603

POMALIDOMIDE PLUS LOW-DEXAMETHASONE TREATMENT FOR ≥ 1 YEAR IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A SUBANALYSIS OF THE MM-013 PHASE 2 STUDY

EHA Library, Dawn Martucci, 267604

THE IMPACT OF DEPTH OF RESPONSE BEFORE AND AFTER AUTOLOGOUS STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA PATIENTS

EHA Library, Sofia Durão, 267605

FEASIBILITY, TOLERABILITY AND EFFICACY OF CARFILZOMIB, LENALIDOMIDE AND DESAMETHASONE(KRD) IN RELAPSED REFRACTORY MYELOMA PATIENTS: A REAL-LIFE SURVEY OF THE SICILIAN MYELOMA NETWORK

EHA Library, Uros Markovic, 267606

OVERALL SURVIVAL OF MULTIPLE MYELOMA (MM) PATIENTS IN COLOMBIA: REPORT OF THE COLOMBIAN REGISTRY FOR HEMATO-ONCOLOGICAL DISEASES (RENEHOC) ASOCIACIÓN COLOMBIANA DE HEMATOLOGÍA Y ONCOLOGÍA (ACHO)

EHA Library, Virginia Abello, 267607

CLINICAL BENEFIT OF LONG-TERM DISEASE CONTROL WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS

EHA Library, Uros Markovic, 267608

IMPACT OF THE PRE-TRANSPLANT INDUCTION (PTI) DURATION ON THE SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA (MM)

EHA Library, Susana Gonçalves Pereira, 267609

SUBGROUP ANALYSIS OF PATIENTS FROM CANADA AND THE UNITED STATES IN THE PHASE 3 FIRST TRIAL IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Dawn Martucci, 267610

PRESCRIPTION PATTERNS AND OUTCOMES OF FIRST-LINE THERAPY FOR NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA REAL-LIFE PATIENTS ACCORDING TO AGE: A RETROSPECTIVE ANALYSIS OF THE 2012-2016 PERIOD

EHA Library, Javier de la, 267611

POMALIDOMIDE + BORTEZOMIB + LOW-DOSE DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS OF THE PHASE 3 OPTIMISMM TRIAL

EHA Library, Dawn Martucci, 267612

TIME TO FIRST PLATEAU AS A PROGNOSTIC PREDICTOR IN MULTIPLE MYELOMA

EHA Library, Elif Umit, 267613

TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA WITH HIGH DOSES OF CYCLOPHOPHAMIDE, BORTEZOMIB AND DEXAMETHASONE FOLLOWED BY DOUBLE AUTOLOGOUS HSCT

EHA Library, Marianna Criscuolo, 267614

EPIDEMIOLOGY OF MULTIPLE MYELOMA (MM) IN MOSCOW (RUSSIA)

EHA Library, Olga Vinogradova, 267615

DIAGNOSIS AND MANAGEMENT OF SYSTEMIC AL AMYLOIDOSIS IN REAL WORLD

EHA Library, M Sirvent, 267616

OUTCOME OF FIRST-LINE THERAPY FOR PATIENTS WITH SYSTEMIC LIGHT-CHAIN AMYLOIDOSIS: MONOCENTRIC ANALYSIS

EHA Library, Rubén Fernández, 267617

DARATUMUMAB MONOTHERAPY IN REAL LIFE COMMUNITY SETTING OF REFRACTORY MYELOMA PATIENTS: A RETROSPECTIVE UNICENTRIC STUDY

EHA Library, Uros Markovic, 267618

ANALYSIS OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH MULTIPLE MYELOMA RECEIVING DARATUMUMAB

EHA Library, Tatyana Glazanova, 267619

THE IMPACT OF ENROLLMENT IN CLINICAL TRIALS OF PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Adi Abulafia, 267620

CRUCIAL AGE FOR JAK2 V617F MUTATION: GENDER DIFFERENCES

EHA Library, Marina Stolyar, 267621

PREVALENCE OF JAK2V617F, CALR AND MPL MUTATIONS IN PATIENTS OF MYELOPROLIFERATIVE NEOPLASMS AND SPLANCHNIC VEIN THROMBOSIS IN INDIA

EHA Library, Jasmita Jasmita, 267622

THE FIRST REPORT ON DEVELOPMENT OF THE JAK2V617F ALLELE BURDEN FROM CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL TO JAK2V617F POSITIVE ESSENTIAL THROMBOCYTHEMIA

EHA Library, Vibe Skov, 267623

: RISK FACTORS OF THROMBOSIS AFTER MPN DIAGNOSIS: A RETROSPECTIVE COHORT OF MPN PATIENTS IN BRAZIL

EHA Library, Wellington Fernandes Silva, 267624

RESULTS FROM A REAL-WORLD, RETROSPECTIVE STUDY EVALUATING THE THROMBOEMBOLIC EVENTS AND THE ASSOCIATED RISK FACTORS IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA

EHA Library, Archana Rai, 267625

SURVIVAL OUTCOME OF HIGH-RISK PATIENTS WITH MYELOFIBROSIS TREATED WITH ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONING REGIMENS

EHA Library, JAE HO YOON, 267626

COMPASSIONATE USE OF ROPEGINTERFERON TO TREAT MYELOPROLIFERATIVE NEOPLASMS IN TAIWAN

EHA Library, Oleh Zagrijtschuk, 267627

SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM, EVOLVING TO SIMULTANEOUS CD33 POSITIVE MAST CELL LEUKEMIA AND ACUTE MYELOID LEUKEMIA, TREATED WITH GEMTUZUMAB-OZOGAMICIN

EHA Library, Patricia Lopez Pereira, 267628

AGGRESSIVE SYSTEMIC MASTOCYTOSIS: A DIAGNOSTIC CHALLENGE IN A PATIENT WITH MYOTONIC DYSTROPHY TYPE 2

EHA Library, Nadja Jaekel, 267629

ADJUSTED INDIRECT COMPARISON OF ELTROMBOPAG RELATIVE TO RITUXIMAB OR SPLENECTOMY IN SECOND LINE TREATMENT FOR CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Jorge Félix, 267630

A PHASE II, OPEN-LABEL, PROSPECTIVE STUDY (TAPER) TO ASSESS THE ABILITY OF ELTROMBOPAG TO INDUCE SUSTAINED TREATMENT-FREE REMISSION IN ITP PATIENTS WITH INSUFFICIENT RESPONSE TO CORTICOSTEROIDS

EHA Library, Nichola Cooper, 267631

THE JOURNEY PRO STUDY: FEASIBILITY AND USER ACCEPTANCE OF A SMARTPHONE APP TO ASSESS THE BURDEN OF ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Β-THALASSEMIA (BT), AND MYELOFIBROSIS (MF)

EHA Library, Jennifer Mark, 267632

HEALTHCARE RESOURCE UTILIZATION (HRU) ASSOCIATED WITH MINIMAL RESIDUAL DISEASE (MRD) STATUS IN ADULTS WITH B-CELL PRECURSOR (BCP) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Arnaud Pigneux, 267633

HEALTHCARE RESOURCE UTILIZATION AND EXPENDITURE RELATED TO NOVEL AGENTS TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA IN TAIWAN

EHA Library, Shang-Yi Huang, 267634

REASSESSING THE EFFICACY OF LOW DOSE RASBURICASE FOR MANAGEMENT OF TUMOR LYSIS SYNDROME IN HIGH RISK HEMATOLOGIC MALIGNANCIES

EHA Library, Jonathan Canaani, 267636